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Abstract The molecular basis of capacitative (or store-oper-
ated) Ca2+ entry is still subject to debate. The transient receptor
potential proteins have been hypothesized to be structural
components of store-operated Ca2+ channels and recent evidence
suggests that Trp3 and its closely related homolog Trp6 are
gated by the N-terminal region of the inositol 1,4,5-triphosphate
receptors (InsP3R). In this study, we report the existence of two
isoforms of the human Trp4 protein, referred to as K-hTrp4 and
L-hTrp4. The shorter variant L-hTrp4 is generated through
alternative splicing and lacks the C-terminal amino acids G785^
S868. Using a yeast two-hybrid assay and glutathione-S-
transferase-pulldown experiments, we found that the C-terminus
of K-hTrp4, but not of L-hTrp4, associates in vitro with the C-
terminal domain of the InsP3 receptors type 1, 2 and 3. Thus, we
describe a novel interaction between Trp proteins and InsP3R
and we provide evidence suggesting that the formation of
hTrp4^InsP3R complexes may be regulated by alternative
splicing. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
In many non-excitable cells, depletion of internal Ca2
stores causes Ca2 in£ux from the extracellular space. This
mechanism has been referred to as ‘store-operated’ Ca2 entry
and is thought to regulate a variety of important cellular
functions ranging from secretion, gene transcription, cell pro-
liferation to apoptosis [1]. The sequence of signaling events
leading to the opening of store-operated channels (SOCs) is
far from clear and three major hypotheses have been emitted.
One involves the release from the empty stores of a soluble
messenger that di¡uses to the plasma membrane to activate
SOCs [2]. The second model suggests a physical coupling be-
tween the Ca2 entry channels and the inositol 1,4,5-triphos-
phate receptor (InsP3R) in the endoplasmic reticulum [3,4].
An alternative proposal assumes exocytotic insertion of vesic-
ular channels or regulatory molecules into the plasma mem-
brane [5,6].
As candidates for SOCs, the transient receptor potential
(Trp) and the Trp-like (Trpl) proteins, which mediate light-
activated Ca2 entry in Drosophila photoreceptors, have been
proposed [7]. Since then, seven mammalian Trp homologs
have been cloned and expressed functionally in vitro (reviewed
in [8]). Trp1, Trp2 and Trp4 appear to be gated by Ca2 store
depletion alone whereas Trp3, Trp6 and Trp7 further require
a product of receptor-stimulated phospholipase C (PLC) for
their activation. Recent ¢ndings strongly support the idea that
Trp3 is gated by a conformational coupling mechanism. First,
in human embryonic kidney (HEK) 293 cells, activation of the
overexpressed Trp3 can be blocked by displacing the endo-
plasmic reticulum from sites of close interaction with the plas-
ma membrane [9]. Secondly, in excised membrane patches,
Trp3 channels can be activated by addition of vesicles con-
taining InsP3-liganded InsP3R [10]. At last, a 289 amino acid
sequence just downstream the InsP3 binding site of the InsP3R
has been shown to associate with the C-termini of both Trp3
and its closely related homolog Trp6 [11].
In this study, we report that the human Trp4 protein also
binds in vitro to InsP3R. While Trp3 and Trp6 are gated by
the N-terminal region of InsP3R, hTrp4 associates with the
C-terminal domain of the intracellular Ca2 release channels.
The interaction is lost upon removal of 84 amino acids in the
hTrp4 C-terminus resulting from alternative RNA splicing.
2. Materials and methods
2.1. Materials
Restriction endonucleases were purchased from Promega. DMEM-
F12, fetal calf serum and Geneticin were obtained from Gibco BRL.
All other chemicals were obtained from Fluka or Sigma. HEK293
cells were from the American Type Culture Collection (Rockville,
MD, USA). 293T cells were a gift from Dr. Didier Trono (Depart-
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ment of Genetics and Microbiology, Centre Medical Universitaire,
Geneva, Switzerland).
2.2. Ampli¢cation by polymerase chain reaction (PCR) of the coding
sequence of the hTrp4 cDNA
PolyA mRNA was puri¢ed from 293T cells using the Fast Track
2.0 kit (Invitrogen). First-strand cDNA was synthesized by using the
avian myeloblastosis virus reverse transcriptase (Invitrogen) and either
oligo-dT or random hexamers as primers. Three sets of speci¢c oligo-
nucleotides were used to amplify by PCR the entire coding region of
the hTrp4 cDNA: FNTrp4 (TAG (C/G)AT GGC (A/C)TG AAC
ATG GC(T/G) CAG) and RNTrp4 (CGT ACC AGC GAG ATG
CCA GCA GCT GTT GAC), FHTrp4 (GTC AAC AGC TGC TGG
CAT CTC GCT GG) and RHTrp4 (CTG CAT GGT CAG CAA
TCA GTT GG), FCTrp4 (GAG TTT GTT GGT GCC ACC ATG
TTT GGG AC) and RCTrp4 (ATA CGT ATG TGT ATG GTA
AAA GCT TCC TCC). The primers were designed according to par-
tial hTrp4 cDNA sequences deposited in the GenBank database under
the accession numbers U40983 [12], C21545 and AA629948. The PCR
mixture typically contained ¢rst-strand cDNA (50 ng), 0.2 mM dNTP,
0.2 WM primers, 1.5^4.5 mM MgCl2 and 1 U Taq polymerase (Qia-
gen). After an initial step of denaturation (94‡C for 1 min), 35^40
cycles of PCR were carried out in a Trio thermoblock thermocycler
(Biometra) set to 94‡C for 30 s, 50^60‡C for 40 s, 72‡C for 75 s,
followed by a ¢nal extension at 72‡C for 10 min. The resulting
DNA fragments were puri¢ed by agarose gel electrophoresis and sub-
cloned into the pGEM-T vector (Promega). For each PCR product,
four to six independent clones were sequenced with a Perkin Elmer
automated sequencer and the ABIPRISM Dye Terminator Cycle se-
quencing kit (Perkin Elmer).
2.3. Cloning of the 5P-untranslated region by rapid ampli¢cation of
cDNA ends (RACE)-PCR
A library for RACE by PCR was prepared, using 1 Wg of 293T
mRNA, random hexamers as primers, and reagents provided by Clon-
tech in the Marathon cDNA ampli¢cation kit. Two sequential RACE
steps were conducted using the Advantage Klen Taq polymerase mix
(from Clontech). Primary RACE-PCR was performed using the
adapter-ligated primer AP1 (5P-CCA TCC TAA TAC GAC TCA
CTA TAG GGC-3P, Clontech) in combination with the hTrp4 speci¢c
antisense primer R1 (5P-CAG CTC AAC AGC TCC GAC GAC
TTC-3P). Nested PCR ampli¢cation was then carried out with internal
primers AP2 (5P-ACT CAC TAT AGG GCT CGA GCG GC-3P,
Clontech) and R2 (5P-GAG TAG TTC GAT GAG CTC CAA G-
3P). The thermocycler was programmed as follows: initial denatura-
tion at 94‡C for 1 min; 35 cycles: 94‡C for 30 s, 68‡C for 2 min. The
resulting product was gel puri¢ed, subcloned into the pGEM-T vector
and sequenced.
2.4. Northern blot analysis
Human multiple tissue Northern blot I (Clontech) was prehybrid-
ized for 3 h at 65‡C in 500 mM NaHPO4 (pH 7), 7% sodium lauryl
sulfate, 1% bovine serum albumin and 1 mM EDTA [13] and then
hybridized in the same bu¡er with 4U106 cpm/ml 32P-labeled probe
for 16 h at 65‡C. The ¢lter was washed at room temperature for
15 min twice with 2USSC/0.1% SDS, once with 1USSC/0.1% SDS,
once with 0.1USSC/0.1% SDS and at 65‡C twice with 0.2USSC/0.1%
SDS for 10 min. The probe was made from a 1 kb restriction frag-
ment encoding the hTrp4 hydrophobic core, labeled by random prim-
ing (Promega) with 32P-dCTP. Autoradiography was carried out for
3^8 days with intensifying screens. After washing out of the hTrp4
probe, the ¢lter was rehybridized with a L-actin probe (Clontech) as a
control.
2.5. Southern blot analysis
cDNAs (1 ng) from the human multiple tissue cDNA panel I (Clon-
tech) were used as template in PCR reactions in combination with
either the FCTrp4 and RCTrp4 oligonucleotides or the control prim-
ers (FG3PDH, 5P-TGA AGG TCG GAG CAA CGG ATT TGG
T-3P and RG3PDH, 5P-CAT GTG GGC CAT GAG GTC CAC
CAC-3P). 20 to 35 cycles of ampli¢cation were carried out with Taq
polymerase (Qiagen). Aliquots of the PCR mixture were separated on
a 1% agarose gel, capillary transferred to a nylon membrane (Elec-
tran, BDH) and then immobilized by UV irradiation. Southern blots
were prehybridized at 65‡C for 3 h in 6USSC/5UDenhardt’s reagent/
1% SDS/1 mM EDTA/50 mM NaHPO4 (pH 7) and then hybridized
in the same bu¡er with a 32P 5P-end-labeled oligonucleotide that rec-
ognizes the sequence £anked by the primers used for PCR ampli¢ca-
tion. Two di¡erent probes were used as probes: P1 (5P-GTG AAG
CGA TAC GTT GCT GC-3P) served to monitor the expression of the
hTrp4 splice variants whereas P2 (5P-CAT CAT CCC TGC CTC
TAC TG-3P) allowed the determination of the glyceraldehyde-3-phos-
phate dehydrogenase (G3PDH) transcript levels in each cDNA prep-
aration. The ¢lters were washed at room temperature for 15 min twice
with 6USSC/0.1% SDS, twice with 2USSC/0.1% SDS and twice with
0.2USSC/0.1% SDS. Autoradiography was carried out for 1^4 h with
intensifying screens.
2.6. Genomic analysis
Genomic DNA was prepared from HEK293 cells using the DNA-
zol reagent (Gibco BRL). The region of the Trp4 gene encoding the
amino acids I692 to R894 (Fig. 1A) was ampli¢ed by PCR using the
oligonucleotides SGTrp4 (5P-CAA TAG GGA GGC GAG CTG
CTG A-3P) and RGTrp4 (5P-CCC GTG AAG CTA ATC CTC
GCA G-3P) as primers. The resulting 3 kb PCR product was sub-
cloned into the pGEM-T vector (Promega) and three independent
clones were sequenced.
2.7. Construction of the full length clones and subcloning into the
expression vector pIRES-enhanced yellow £uorescent protein
(EYFP)
Overlapping PCR fragments (subcloned into the pGEM-T vector)
were ligated together to give the full length cDNAs encoding the K-
and L-hTrp4 variants. The 5P-untranslated region was removed and
both constructs were epitope-tagged at the N-terminus with the c-myc
peptide MEQKLISEEDLLR. The ¢rst methionine codon was in-
cluded within the sequence characteristics for translation initiation
5P-GCCGCCATGG-3P as speci¢ed by Kozak [14]. These constructs
were controlled by sequencing and then subcloned into the Not1 site
of the pIRES-EYFP vector (Clontech).
2.8. Yeast two-hybrid assay
The full length cDNA encoding the InsP3R isoform 2 was cloned
from rat liver using the long template PCR system from Boehringer
Mannheim (Roche, Basel, Switzerland). The cDNAs encoding the
InsP3R type 1 and 3 were kindly provided by Dr. Mignery and Dr.
Bell respectively. Overlapping DNA fragments encompassing the N-
and C-terminal domains of the InsP3R type 2 or the C-terminal re-
gions of the InsP3R type 1, 2 and 3 were generated by PCR with
mutant primers containing appropriate restriction sites. The con-
structs were con¢rmed by sequencing and then subcloned into the
pACT2 vector (Clontech) which encodes the Gal4-activating domain
(Gal4-AD). The complete C-termini of K-hTrp4 (M615 to L977) and L-
hTrp4 (M615 to L893) were fused to the Gal4-DNA binding domain
(Gal4-BD) encoded by the pAS1 vector (ATCC). Yeast two-hybrid
assays were performed with the AH109 strain (Clontech). Yeast trans-
formations were conducted according to the Matchmaker II user
manual (Clontech). Recombinant yeast presenting a blue phenotype
when streaked out on agar plates lacking adenine, histidine, leucine
and tryptophan and supplemented with K-Gal (Clontech) were con-
sidered as positives.
2.9. Glutathione-S-transferase (GST)-pulldown assays
The DNA fragment encoding the C-terminus of the rat InsP3 re-
ceptor type 2 (amino acids 2544^2701) was subcloned into the GST
fusion protein vector, pGEX-5X-1 (Pharmacia Biotech). The GST-
IP3RCter fusion protein was expressed in BL21 Escherichia coli strain
and puri¢ed according to the manufacturer’s instructions. Brie£y,
IPTG-induced bacteria were harvested and resuspended in PBS con-
taining 1% Triton X-100 and a cocktail of protease inhibitors (Boehr-
inger Mannheim). Cells were lysed by sonication and then centrifuged
at 13 000 rpm for 5 min at 4‡C. The supernatant was incubated with
glutathione-Sepharose beads (Pharmacia Biotech) for 15 min at room
temperature. After three washes with the lysis bu¡er, an aliquot of
beads (50 Wl of bed volume) was removed: bound proteins were eluted
with 10 mM glutathione, analyzed on 12% SDS^PAGE and then
stained with Coomassie blue.
HEK293 cells were cultured in DMEM-F12 medium supplemented
with 10% heat-inactivated fetal calf serum, 50 U/ml penicillin and
50 Wg/ml streptomycin. Transfections were carried out by the calcium
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phosphate coprecipitation method as described by Chen and Okaya-
ma [15]. Cells were lysed 48 h posttransfection in PBS containing 1%
Triton X-100 and a cocktail of protease inhibitors (Boehringer Mann-
heim). Protein concentrations were measured with the BCA protein
assay kit (Pierce). GST-pulldown experiments were performed by mix-
ing 100 Wl of cell lysate (300 Wg of total protein) with beads charged
with either GST or the GST-IP3RCter fusion protein, for 16 h at 4‡C.
The beads were then washed three times with the lysis bu¡er at 4‡C.
Bound proteins were eluted with 40 Wl of 2ULaemli bu¡er and ana-
lyzed by SDS^PAGE and immunoblot. Blots were probed with an
anti-c-myc antibody (1/500, clone 9E10, Boehringer Mannheim) and
developed using a horseradish peroxidase-conjugated goat anti-mouse
IgG (Amersham) and an enhanced chemoluminescence detection sys-
tem (ECL Amersham).
3. Results and discussion
A PCR-based strategy was used to clone the human Trp4
cDNA as described in experimental procedures. 293T cells
were found to coexpress two hTrp4 isoforms referred to as
K and L. K-hTrp4 is composed of 977 amino acids (Fig. 1A)
and shows 96.7%, 96.6% and 88% sequence identity to bovine
[16], mice [17], and rat [18] homologs respectively. The L var-
iant has also been identi¢ed in mice tissues [17] and lacks the
residues G785 to S868. The latter are encoded by a 252 bp
sequence (Fig. 1B) £anked by consensus splice donor and
splice acceptor dinucleotides (GT and AG respectively). This
suggests that the 252 bp cassette is not a true exon but an
intron that can be either retained or spliced out during pro-
cessing of the hTrp4 pre-mRNA. To test this hypothesis, ge-
nomic DNA was prepared from HEK293 cells and used as a
template in a PCR reaction, in combination with sense and
antisense primers to regions surrounding the deletion. As
shown in Fig. 1C, the 3 kb PCR product that was obtained
is composed of four exons (E1^E4), two invariable introns (I1
and I2) and one alternative intron (Ia). Surprisingly, the sites
that £anked Ia match the splice donor (AGGTAAGT) and
acceptor ((T/C)6NCAG) consensus [19] better than the se-
quences found at the boundaries of I1 and I2 (Fig. 1D).
Thus, the fact that Ia is spliced out less e⁄ciently than other
introns is not due to mediocre splice acceptor or donor sites.
The occurrence of the hTrp4 C-terminal diversity prompted
us to investigate whether any tissue speci¢c regulation of this
alternative splicing exists. Northern blot analysis (Fig. 2A)
revealed that hTrp4 is strongly expressed in placenta. Inter-
mediate message levels were observed in heart, pancreas, kid-
Fig. 1. Identi¢cation of the hTrp4 isoforms. A: Primary structure of K-hTrp4. Ankyrin-like motifs, coiled-coil structure and hydrophobic seg-
ments are indicated by single underlines, dotted underlines and shadow, respectively. Amino acids are numbered starting from the ¢rst methio-
nine. B: Analysis of PCR products generated using 293T cDNA as a template, FCTrp4 and RCTrp4 as primers: molecular weight markers
(lane 1) and PCR products (lane 2) were electrophoresed on a 1% agarose gel and visualized with ethidium bromide. Nucleotides that are miss-
ing in the L variant are indicated in parentheses. The sequences of K- and L-hTrp4 have been submitted to the GenBank database under the ac-
cession numbers AF063822 and AF063823 respectively. C: Structure of the region in the Trp4 gene encoding the amino acids I692 to R894.
Shaded boxes represent exons and horizontal lines, introns. Length of appropriate units is indicated in the boxes or above lines in bp. The al-
ternative intron is termed Ia. D: Sequence of exon/intron boundaries. Capital letters represent exon sequences and lowercase letters, intron se-
quences.
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ney and brain whereas virtually no signal was found in skel-
etal muscle, liver and lung. Four di¡erent transcript sizes were
detectable: a doublet at 3.6^3.9 kb and minor species at 6.8
and 8.7 kb. This size heterogeneity was also observed for rat,
mice and bovine Trp4 messengers and might be due to either
alternative splicing, alternative use of polyadenylation signals
or incompletely processed mRNA.
RT-PCR was next performed to estimate the contribution
of the K and L isoforms to the total pool of hTrp4 messengers.
First-strand cDNAs of the human MTC panel I (Clontech)
were used as templates. Ampli¢cations were stopped before
reaching the plateau phase and the products were visualized
following Southern blotting, hybridization and autoradiogra-
phy. The expression pro¢le of G3PDH was included as a
control for loading and PCR e⁄ciency. As shown in Fig.
2B, K was the predominant isoform in all the hTrp4-positive
tissues. The L variant was detected in placenta, kidney and
heart but not in brain. Interestingly, we found in placenta an
additional product almost as abundant as the L isoform. Note
that this C-terminal polymorphism appears to be a speci¢c
feature of Trp4. Indeed, other Trp homologs have been shown
Fig. 2. Tissue distribution of hTrp4 messenger RNAs. A: Northern blot analysis of hTrp4 mRNA expression. Human adult multiple tissue
mRNA blot I (Clontech) was hybridized with a 32P-labeled probe encoding the hTrp4 hydrophobic core. The lower panel shows the same ¢lter
reprobed with a 2 kb L-actin probe (Clontech). B: Tissue distribution of alternative C-terminal splice variants of hTrp4. First-strand cDNAs of
the MTC panel I (Clontech) were used as PCR templates with primers speci¢c for either the C-terminal domain of hTrp4 (upper panel) or the
G3PDH (lower panel). PCR products were visualized following Southern blotting, hybridization and autoradiography as described in Section 2.
The negative control corresponds to an ampli¢cation performed without template. The results shown are representatives of two independent ex-
periments.
6
Fig. 3. Interaction between the hTrp4 variants and the InsP3 recep-
tor type 2. A: Schematic description of the preys (P1^P6) and the
baits (B1 and B2) used in the yeast two-hybrid assay. The linear di-
agrams of the InsP3R type 2 and the hTrp4 isoforms are repre-
sented with the same scale. Beginning and ending amino acid num-
bers of the fragments fused to the Gal4-activating domain (P1^P6)
or to the Gal4 binding domain (B1 and B2) are indicated. TM,
transmembrane segments; Ia, alternative intron. B: Results of the
yeast two-hybrid screen. A positive interaction was found only be-
tween the C-terminus of the K variant and the C-terminal domain
of the InsP3R type 2, as shown by growth and acquisition of a blue
phenotype on a selective medium devoid of leucine, tryptophan, ad-
enine, histidine and supplemented with K-Gal.
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to exhibit structural variants [20^23]. However, in all those
cases it was the N-terminal region or the hydrophobic core
that was truncated.
Presently available data suggest that bTrp4 (which closely
resembles K-hTrp4) is a component of SOCs. Transfection of
bTrp4 in either HEK293 or CHO cells resulted in the forma-
tion of Ca2 selective channels activated by InsP3 or thapsi-
gargin-induced store depletion [16,24]. Furthermore, transient
expression of bTrp4 in antisense orientation was shown to
reduce both the amount of native Trp4 protein and the ca-
pacitative Ca2 in£ux in adrenal cells [25]. As new evidence
has recently emerged indicating that InsP3R interacts with
SOCs to control Ca2 entry [9,26] and because the C-terminal
tail of Trp proteins has been shown to play a crucial role in
channel gating [27], we investigated the association of the K-
and L-hTrp4 C-termini with InsP3R.
A yeast two-hybrid assay was ¢rst set up to test the for-
mation of Trp4^InsP3R complexes. Six preys denoted P1^P6
(Fig. 3A) were designed, encompassing the N- and C-terminal
domains of the rat InsP3R type 2 (96% homology to the
human InsP3R type 2). They were subcloned into the
pACT2 vector, downstream the Gal4-activating domain. We
used as bait the complete C-terminus of either K-hTrp4 or L-
hTrp4 fused to the Gal4-DNA binding domain. Yeast strain
AH109 was cotransformed with the bait and prey vectors and
proper expression of the fusion proteins was controlled by
Western blot analysis (data not shown). None of the N-ter-
minal preys associated with the hTrp4 isoforms in the two-
hybrid assay. In contrast, an interaction was found between
the C-terminal tail of the InsP3R type 2 and the C-terminus of
K- but not L-hTrp4, as shown by growth on selective media
and by positive galactosidase assay. The C-terminal domains
of the three InsP3 receptor subtypes are closely related (Fig.
4A). To test whether all isoforms could sustain the interac-
tion, we cloned into pACT2 the C-termini of the InsP3R type
1 and 3. The latter bound to the C-terminus of K-hTrp4 in a
similar manner as the InsP3R isoform 2 (Fig. 4B).
To con¢rm the interaction found in the yeast two-hybrid
assay, we next performed GST-pulldown experiments. N-myc-
tagged hTrp4 isoforms were expressed in HEK293 cells and
cell extracts were incubated with GST or with the GST-
IP3RCter fusion protein immobilized on glutathione-Sephar-
ose beads. The latter were then extensively washed and the
bound proteins were analyzed by immunoblotting. As shown
in Fig. 5, N-myc-tagged K-hTrp4 but not L-hTrp4 was able to
bind to the GST-P6 fusion protein whereas no signi¢cant
Fig. 4. Binding of the C-terminus of K-hTrp4 to the C-terminal domains of the InsP3 receptors type 1 and 3. A: Sequence alignment of the
C-terminal domains of rat InsP3R type 1 (accession number: J05510), 2 (X61677) and 3 (L06096). The C-terminal sequence of the ryanodine
receptor is shown for comparison. Amino acids are numbered starting from the ¢rst methionine. Conserved residues are shaded. B: Plasmids
encoding the C-terminus of either the InsP3R type 1 or the InsP3R type 3 fused to the Gal4-activating domain were cotransfected with the B1-
pAS1 construct into the reporter strain AH109. Colony growth on the His/Ade-de¢cient medium, showing activation of the nutritional reporter
genes, was controlled after 2 days. An K-Gal assay was also performed to con¢rm the interaction.
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interaction was detected between the GST alone and N-myc-
tagged K-hTrp4. Protein staining with Coomassie blue (Fig. 5,
left panel) demonstrated that equivalent amounts of GST and
GST-IP3RCter fusion protein were present in each pulldown.
Taken together, our results suggest that K-hTrp4, like Trp3
and Trp6, may be physically coupled to InsP3 receptors. They
also indicate that the formation of hTrp4^InsP3R complexes
may be regulated by alternative splicing of the hTrp4 mRNA.
To our knowledge, this is the ¢rst evidence that alternative
splicing may modify the properties of Trp proteins. K-hTrp4
and Trp3 do not preferentially bind to the same domain of the
InsP3R. Indeed, no interaction was found in the yeast two-
hybrid assay between K-hTrp4 and the P2 prey which con-
tained a sequence (residues 752^822) conserved in the three
InsP3R subtypes and that has been proposed to form the
signal-transfer domain of the InsP3R to Trp3 [11]. Presently
available data suggest that Trp3 is not a store-operated chan-
nel in the strictest sense. Indeed, as opposed to SOCs, Trp3
requires InsP3-liganded InsP3R for its activation [10,28] and
can be gated by diacylglycerol independently of store deple-
tion [29]. On the other hand, Ma et al. [9] demonstrated that,
in HEK293 cells, Trp3 and endogenous SOC activities can be
blocked by the same pharmacological agents leading either to
a rearrangement of the actin cytoskeleton or to the inhibition
of the InsP3R function. We propose that the di¡erential in-
teraction of K-hTrp4 and Trp3 with InsP3R may explain this
apparent contradiction.
One of the main arguments against the conformational cou-
pling model is the fact that removal of all three InsP3R iso-
forms by genetic means in chicken B lymphocytes had no
e¡ect on thapsigargin-induced Ca2 in£ux [30]. However,
the C-terminus of InsP3R closely resembles the C-terminal
domain of ryanodine receptors (Fig. 4), thus the latter may
substitute for InsP3R to activate Ca2 entry in the InsP3R
mutants. In support of this hypothesis, depletion of ca¡eine-
sensitive Ca2 stores in some cell types has been shown to
promote capacitative Ca2 entry [31,32].
In conclusion, we report the primary sequence and the ex-
pression patterns of two isoforms of the human Trp homo-
logue hTrp4. The two variants arise from alternative process-
ing of the mRNA and di¡er in the length of their C-terminal
domains. The C-terminus of the long (K-hTrp4), but not the
short (L-hTrp4) variant, is able to bind to the three InsP3R
isoforms in vitro. As opposed to Trp3 and Trp6 that interact
with an N-terminal region of the InsP3R, K-hTrp4 associates
with the C-terminus of the intracellular Ca2 release channel.
These results are compatible with recent ¢ndings suggesting
that store-operated Ca2 channels are regulated by an Ins-
P3R-dependent conformational coupling mechanism. They
also suggest that alternative splicing of Trp mRNA may gen-
erate channels with distinct properties.
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